At the AAN conference, a leading expert provided an overview of ongoing research into the longer-term neurological consequences of acute COVID-19 infection.
Prof. Serena Spudich, Professor of Neurology and Chief of the Division of Neurological Infections & Global Neurology, at Yale School of Medicine, New Haven, Connecticut, USA, noted: “A subset of patients manifests acute neurological issues when they are initially ill with COVID-19. Even early in the pandemic we began to hear reports of persistent or emergent neurological complications in people surviving the acute illness.” These include a wide spectrum of cognitive, mood, sensory, motor, autonomic, and headache symptoms, she said.